Global Regulatory Affairs Market to reach USD 20.75 Billion by 2027.Global Regulatory Affairs Market is valued approximately at USD 11.8 Billion in 2020 and is anticipated to grow with a healthy growth rate of more than 8.4% over the forecast period 2021-2027. Regulatory Affairs (RA) is also known as Government Affairs, it is a profession within regulation industries, such as pharmaceuticals, energy, medical devices, and banking. The global Regulatory Affairs market is being driven by demand for faster approval process for breakthrough drugs and devices, growth in emerging areas such as personalized medicine, biosimilars, and orphan drugs. Furthermore, life science companies focusing on their core competencies and economic and competitive pressures, will provide new opportunities for the global Regulatory Affairs industry. For instance, according to Steve Gens Report published 2018, nearly around 58% of pharma companies covered under survey had planned to enhance the Regulatory Intelligence (RI) capability of their companies, while another study states that about 20 out of 22 participating companies had considered AI for RI data as a leveraging processing activities. As a result, increased in adoption of AI and RI by the companies, will serve as a catalyst for the Regulatory Affairs industry in the future. However, risk associated with data security and monitoring issues and lack of standardization, may impede market growth over the forecast period of 2021-2027.

Asia Pacific, North America, Europe, Latin America, and Rest of the World are the key region considered for the regional analysis of global regulatory affairs. Low cost for outsourcing, presence of skilled workforce along with technical expertise, tax benefits, and the expansion of healthcare companies makes the Asia Pacific the leading region across the world in terms of market share. Whereas Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to supportive regulatory landscape.
Major market player included in this report are:

Accell Clinical Research, LLC.
GenPact Ltd.
Criterium, Inc.
PRA Health Sciences
Promedica International
WuXi AppTec, Inc.
Medpace
Charles River Laboratories International, Inc.
ICON pl

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Service:
Regulatory consulting
Legal representation
Regulatory writing & publishing
Product registration & clinical trial applications
Other services
By Category:
Drugs
Biologics
Medical Devices
By Indication:
Oncology
Neurology
Cardiology
Immunology
Other Indications
By product stage:
Preclinical
Clinical
PMA
by end use
Medical Device Companies
Biotechnology Companies
Pharmaceutical Companies
by company size:
Small
Medium
Large

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Global Regulatory Affairs Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors